Cafepharma Today

June 2 2025 - Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Sanofi expands rare immunology portfolio with Blueprint buyout
Moderna's next-gen COVID shot gets FDA backing with some limitations
BioNTech flips its cancer bispecific to BMS for a big profit
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

FDA Advisory Meeting Leaves Zogenix Stock In Tatters
Seeking Alpha
Friday, December 14, 2012 - 12:34pm
tags:
FDA, Zogenix, Zohydro
Roche looks to earn even more from Perjeta with EU nod
Fierce Pharma
Friday, December 14, 2012 - 12:32pm
tags:
Roche, Perjeta, Europe, breast cancer
Ariad Wins Approval for Drug to Treat Rare Leukemias, FDA Says
Bloomberg
Friday, December 14, 2012 - 12:31pm
tags:
Ariad Pharmaceuticals, FDA, chronic myeloid leukemia, Iclusig
Amicus Soon To Release New Phase III Data
Seeking Alpha
Friday, December 14, 2012 - 12:30pm
tags:
Amicus, AT1001, Amigal, Migalastat HCl, Fabry's disease
Lpath Announces Pricing of Public Offering of Common Stock
Yahoo
Friday, December 14, 2012 - 12:28pm
tags:
Lpath, stock offering
4 Reasons Amarin Will Keep Tanking
Seeking Alpha
Friday, December 14, 2012 - 11:52am
tags:
Amarin
EU panel recommends approval of Alexza's Adasuve
Yahoo/AP
Friday, December 14, 2012 - 11:51am
tags:
Europe, Alexza, Adasuve, schizophrenia
Lundbeck’s Anti-Alcoholism Pill Wins EU Regulatory Nod
Bloomberg
Friday, December 14, 2012 - 11:50am
tags:
Lundbeck, alcoholism, Selincro, Europe
Pfizer/Ligand get PDUFA date for menopause combo
Pharma Times, UK
Friday, December 14, 2012 - 11:49am
tags:
Pfizer, Ligand, menopause, bazedoxifene/conjugated estrogens
Cambridge biotech Vaxxas teams with Merck
Boston Herald, MA
Friday, December 14, 2012 - 11:48am
tags:
Vaxxas, Merck, vaccines, Nanopatch
Genzyme, Isis say CHMP adopts negative opinion on KYNAMRO
Yahoo/Fly on the Wall
Friday, December 14, 2012 - 11:47am
tags:
Genzyme, Isis Pharmaceuticals, Kynamro, CHMP, Homozygous Familial Hypercholesterolemia
AbbVie's Outlook Highly Dependent on Well-Positioned Humira
Yahoo/Morningstar
Friday, December 14, 2012 - 11:42am
tags:
Humira, AbbVie
Pfizer to launch animal-health unit IPO in early 2013, may raise $4 billion
Reuters
Friday, December 14, 2012 - 11:41am
tags:
Pfizer, IPO, animal health, Zoetis
Mayne Pharma Seeks $19 Million to Fund GlaxoSmithKline Deal
WSJ Online
Friday, December 14, 2012 - 11:36am
tags:
GSK, Mayne Pharma, Australia, Kapanol
Sarepta CEO: $125 Million Offering Demand Was Strong
TheStreet.com
Thursday, December 13, 2012 - 4:30pm
tags:
Sarepta, Chris Garabedian
ArQule: An Inexpensive And Well-Financed Oncology Opportunity
Seeking Alpha
Thursday, December 13, 2012 - 4:29pm
tags:
Arqule, Daiichi Sankyo, ARQ-087
Teva agrees licensing deal for Xenon pain drug
Zenopa
Thursday, December 13, 2012 - 4:27pm
tags:
Teva, Xenon, XEN402
Warner Chilcott Stock Hits New 52-Week Low
TheStreet.com
Thursday, December 13, 2012 - 4:24pm
tags:
Warner Chilcott
Synta Pharma: Poised For A Breakout With 4 Near-Term Catalysts
Seeking Alpha
Thursday, December 13, 2012 - 4:23pm
tags:
Synta Pharmaceuticals, Ariad Pharma, GSK, Bristol-Myers Squibb
3 Keys From Avanir's Quarterly Results
Motley Fool
Thursday, December 13, 2012 - 4:22pm
tags:
Avanir, earnings

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.